menu search

Cassava sciences: my bullish take on biomarkers and ctad data

Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candid...

October 30, 2023, 3:30 am

Novo nordisk just consolidated its grip on yet another market. is it a buy?

Novo Nordisk just acquired a promising pharmaceutical asset for kidney disease. The candidate could als...

October 29, 2023, 9:30 am

Ironwood pharmaceuticals: the right play now

Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gastrointestinal disorders. The company's revenue-g...

October 27, 2023, 4:13 pm

2 green flags and 1 red flag for novartis stock

Novartis just spun off Sandoz, its generic division. The company has a huge pipeline of upcoming drug candid...

October 27, 2023, 5:05 am

Pfizer's combination flu and covid vaccine candidates effective, trial data shows

Shares of Pfizer Inc (NYSE:PFE) and its German partner BioNTech rose after the two companies announced positive results from a Phase 1/2 study evalua...

October 26, 2023, 2:45 pm

Biovie says blinded data points to hopeful alzheimer's treatment potential

BioVie Inc (NASDAQ:BIVI) said that blinded data presented at the 16th Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston suggests its ...

October 25, 2023, 2:19 pm

Medivir to report new and updated data from ongoing phase 2a hcc study as part of its q3 report on friday

Webcasted Conference Call on Friday, October 27, 2023 at 14.00 CET STOCKHOLM , Oct. 25, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a ph...

October 25, 2023, 2:46 am

Tom emmer will be the next gop nominee for the speaker of the house.

Rep. Tom Emmer (R-Minn.) will be the next nominee for House speaker after winning the first three rounds of the Republican nomination contest.He has r...

October 24, 2023, 4:39 pm

Ambrx: next-generation antibody-drug conjugates, buying the dip after esmo data

Ambrx Biopharma Inc. common stock experienced an irrational selloff following the Phase 1/2 ESMO data release for its ADC ...

October 24, 2023, 11:23 am

Oxford cannabinoid technologies delighted with phase 1 outcome for pain drug

Clarissa Sowemimo-Coker, CEO of Oxford Cannabinoid Technologies Holdings, discusses with Proactive's Thomas Warner the successful completion of a phas...

October 24, 2023, 9:46 am

Forexlive asia-pacific fx news wrap: us yields weigh on us dollar. separately, btc soars.

Morgan Stanley's Wilson "remains comfortable" with year-end 3900 S&P500 targetToyota near solid-state battery breakthrough: 1,200-km range, 10-min cha...

October 24, 2023, 3:29 am

First meeting of china - us economic working group, candid and constructive discussions

China finance ministry readout: Two sides had in-depth, candid and constructive discussions on the macr...

October 24, 2023, 1:37 am

Argentina equities show mixed action after presidential election leaves far-right candidate gasping for air

Argentina’s November runoff election will pit two contrasting economic and political models against each other in a country battered by inflation an...

October 23, 2023, 11:59 pm

Why cymabay therapeutics stock rocketed nearly 8% higher today

The leading drug candidate in the biotech's pipeline scored another win. Seladelpar's existing Breakthr...

October 23, 2023, 6:16 pm

Cargo therapeutics begins $100 million ipo rollout

Cargo Therapeutics, Inc. has filed for a $100 million IPO to develop improved CAR T-cell therapy for large B-cell lymphoma. The company's lead ...

October 23, 2023, 5:47 pm

Intellia (ntla) focuses on developing gene-editing therapies

Intellia's (NTLA) in-vivo CRISPR-based gene-edited therapy candidate NTLA-2001 holds potential. Other p...

October 23, 2023, 11:18 am

2 reits that could be takeover targets

REITs offer an opportunity to buy real estate at a discount. Private equity players are already taking advantage of this. We highlight 2 likely buyout...

October 23, 2023, 8:05 am

Merck discontinues some cancer drug development with china's sichuan kelun

Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two ...

October 23, 2023, 3:47 am

Pro-bitcoin javier milei trails as argentina’s presidential election goes to run-off

Pro-Bitcoin (BTC) presidential candidate Javier Milei failed to secure victory in the first round of th...

October 23, 2023, 1:59 am

Japan’s ruling ldp won 1 seat and lost 1 seat in sunday’s diet by-elections

There were two by-elections in Japan on Sunday:one for a lower house seatone for an upper house seatthe ruling Liberal Democratic Party won the lower ...

October 23, 2023, 12:35 am


Search within

Pages Search Results: